SCHEMBL10286208

SCHEMBL10286208

CCOc1cc2c(nc1C)C(=O)CCCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
ACHE P22303 1/20 0.36
ALDH1A1 P00352 4/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
MAPT P10636 2/20 0.34
CYP2C9 P11712 1/20 0.34
CASP3 P42574 2/20 0.34
SENP8 Q96LD8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286111 0.83 MAOB (0.33) MAOAMAOBKMT2AMEN1POLB
SCHEMBL10286115 0.83 ALDH1A1 (0.41) KDM4ESMN1; SMN2RXFP1ALDH1A1NPC1
SCHEMBL10286580 0.80 ALDH1A1 (0.44) KDM4ESMN1; SMN2RXFP1ALDH1A1NPC1
SCHEMBL10286109 0.78 HSD17B1 (0.34) KDM4EMAOAMAOB
SCHEMBL10286156 0.76 NPC1 (0.34) KDM4EALDH1A1NPC1RAB9ACYP1A2
SCHEMBL10286632 0.75 HSD17B1 (0.37) KDM4EALDH1A1NPC1RAB9ACYP1A2
SCHEMBL10286121 0.73 RXFP1 (0.42) KDM4ESMN1; SMN2RXFP1ALDH1A1CYP1A2
SCHEMBL10286474 0.73 KDM4E (0.33) KDM4ESMN1; SMN2RXFP1ALDH1A1NPC1
SCHEMBL10286124 0.71 KDM4E (0.36) KDM4EACHEALDH1A1NPC1RAB9A
SCHEMBL10271344 0.71 KDM4E (0.70) KDM4ESMN1; SMN2ACHEALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO KDM4E 1075/4885SMN1; SMN2 4477/4885RXFP1 2356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.